Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 20
The National Academies’ Guidelines for Human Embryonic Stem Cell Research REFERENCES IOM and NRC (Institute of Medicine and National Research Council). 2007. Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report. Washington, D.C.: The National Academies Press. NIH (National Institutes of Health). 2001. Funding of Research Using Specified Existing Human Embryonic Stem Cells. Notice NOT-OD-01-059, National Institutes of Health, release date August 27, 2001. NRC and IOM. 2005. Guidelines for Human Embryonic Stem Cell Research. Washington, D.C.: The National Academies Press. NRC and IOM. 2007. 2007 Amendments to the National Academies’ Guidelines for Human Embryonic Stem Cell Research. Washington, D.C.: The National Academies Press. Park, In-Hyun, Rui Zhao, Jason A. West, Akiko Yabuuchi, Hongguang Hu, Tan A. Ince, Paul H. Lerou, M. William Lensch, and George Q. Daley. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146. Streiffer, Robert. 2008. Informed Consent and Federal Funding for Stem Cell Research, Hastings Center Report 38(3): 40-47. Takahashi, Kazutoshi, and Shinya Yamanaka. 2006. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 126: 663-676. Takahashi, Kazutoshi, Koji Tanabe, Mari Ohnuki, Megumi Narita, Tomoko Ichisaka, Kiichiro Tomoda, and Shinya Yamanaka. 2007. Induction of pluripotent stem cells from adult fibroblasts by defined factors. Cell 131: 1-12. Yu, Junying, Maxim A. Vodyanik, Kim Smuga-Otto, Jessica Antosiewicz-Bourget, Jennifer L. Frane, Shulan Tian, Jeff Nie, Gudrun A. Jonsdottir, Victor Ruotti, Ron Stewart, Igor I. Sluvkin, and James A. Thomson. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.